Ortho-ATI Shoulder Tendon Study Database Lock
Filed with ASX · · 3 pages · English
• The pivotal Ortho-ATI® shoulder tendon study database has been locked and the data submitted for analysis • Reporting of top line results on track for Q4, 2021 • Ortho-ATI® shoulder tendon study is the first randomised cellular therapy study completed for this indication globally • There are currently no proven long-term, non-surgical solutions to repair chronic shoulder tendon injuries • Ortho-
Story so far
Earlier from Orthocell
- Application for quotation of securities - OCC
- Positive Data for CelGro Collagen Rope in ACL Reconstruction
- OCC Secures Patents for Suture-Less Repair of Soft Tissue
- Ortho-ATI Shoulder Tendon Study Update Revised
- Ortho-ATI Shoulder Tendon Study Update
Later from Orthocell
- OrthoATI Tendon Clinical Study Success
- Successful SmrtGraft Shoulder Study Published
- Striate US Market Entry Update
- Regulatory Approval for Remplir Nerve Repair Device
- Notification regarding unquoted securities - OCC
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell